Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Re: Options/ Directors' shareholding

23 Dec 2015 11:06

RNS Number : 0387K
S & U PLC
23 December 2015
 



 S & U PLC ("S&U" or "the Company")

Exercise and Sale of Options/ Directors' Shareholding

23 December 2015

 

S&U plc announces that it has today received due notice of exercise in respect of options granted to a director under the Company's 2008 Discretionary Share Option Plan ("DSOP"). The notice was in respect of a total of 3,000 ordinary shares of 12.5p each ("Ordinary Shares") at the exercise price of 730 pence per share. These 3,000 Ordinary Shares were admitted to trading on 23 December 2015 pursuant to an existing block listing granted to the Company by London Stock Exchange plc and will rank pari passu with existing Ordinary Shares. These shares were placed with 2 Directors at a price of £24.40.

 

Mr Guy Thompson, a Director, exercised and sold 3,000 Ordinary Shares from his DSOP awards at £24.40. He has no shareholding.

 

Mr Anthony Coombs, Chairman, acquired 1,000 Ordinary Shares bringing his shareholding (including beneficial shareholdings) to 1,336,027 Ordinary Shares representing 11.2 per cent of the enlarged ordinary share capital.

 

Mr Graham Coombs, Deputy Chairman, acquired 2,000 Ordinary Shares bringing his shareholding (including beneficial shareholdings) to 1,537,207 Ordinary Shares representing 12.9 per cent of the enlarged ordinary share capital.

 

In addition to the above holdings, Grevayne Properties Limited, a Company beneficially controlled by Anthony Coombs and Graham Coombs, hold 298,048 Ordinary Shares representing 2.5% of the enlarged ordinary share capital.

  

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 11,904,875, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FCA's Disclosure and Transparency rules.

 

For further information, please contact: 

 

S&U plc

www.suplc.co.uk

Anthony Coombs, Chairman

0121 705 7777

 

Broker and Financial Adviser

Chris Hardie / James Felix, Arden Partners

0207 614 5917

 

Media and Investor Relations

Will Swan, Smithfield

0207 360 4900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFXLFLELFBFBL
Date   Source Headline
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.